Article thumbnail

Transgenic Expression of Entire Hepatitis B Virus in Mice Induces Hepatocarcinogenesis Independent of Chronic Liver Injury

By Bing Na, Zhiming Huang, Qian Wang, Zhongxia Qi, Yongjun Tian, Cheng-Chan Lu, Jingwei Yu, Martha A. Hanes, Sanjay Kakar, Eric J. Huang, J.-H. James Ou, Limin Liu and T. S. Benedict Yen


Hepatocellular carcinoma (HCC), the third leading cause of cancer deaths worldwide, is most commonly caused by chronic hepatitis B virus (HBV) infection. However, whether HBV plays any direct role in carcinogenesis, other than indirectly causing chronic liver injury by inciting the host immune response, remains unclear. We have established two independent transgenic mouse lines expressing the complete genome of a mutant HBV (“preS2 mutant”) that is found at much higher frequencies in people with HCC than those without. The transgenic mice show evidence of stress in the endoplasmic reticulum (ER) and overexpression of cyclin D1 in hepatocytes. These mice do not show any evidence of chronic liver injury, but by 2 years of age a majority of the male mice develop hepatocellular neoplasms, including HCC. Unexpectedly, we also found a significant increase in hepatocarcinogenesis independent of necroinflammation in a transgenic line expressing the entire wildtype HBV. As in the mutant HBV mice, HCC was found only in aged—2-year-old—mice of the wildtype HBV line. The karyotype in all the three transgenic lines appears normal and none of the integration sites of the HBV transgene in the mice is near an oncogene or tumor suppressor gene. The significant increase of HCC incidence in all the three transgenic lines—expressing either mutant or wildtype HBV—therefore argues strongly that in absence of chronic necroinflammation, HBV can contribute directly to the development of HCC

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2001). Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes.
  2. (2005). Activation of hepatitis B virus S promoter by a cell type-restricted IRE1-dependent pathway induced by endoplasmic reticulum stress.
  3. (1997). Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum.
  4. (2003). Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
  5. (2003). Caught up in a Wnt storm: Wnt signaling in cancer.
  6. (2002). Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein.
  7. (2005). CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life.
  8. (1990). Differential regulation of the hepatitis B virus surface gene promoters by a second viral enhancer.
  9. (1993). Dysregulated surface gene expression from disrupted hepatitis B virus genomes.
  10. (2002). Enhancement of hepatitis B virus replication by its X protein in transgenic mice.
  11. (2005). ER stress and the unfolded protein response.
  12. (2005). ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth.
  13. (2004). Focus on hepatocellular carcinoma.
  14. (1991). HBx gene of hepatitis B virus induces liver cancer in transgenic mice.
  15. (2007). Hepadnaviruses In:
  16. (2007). Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice.
  17. (2001). Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.
  18. (2003). High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity.
  19. (1994). High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice.
  20. (1995). High-level hepatitis B virus replication in transgenic mice.
  21. (2002). Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants.
  22. (2000). Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection.
  23. (1998). Immune pathogenesis of hepatocellular carcinoma.
  24. (1993). Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier.
  25. (1996). Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME.
  26. (2007). Injection-mediated transposon transgenesis in Xenopus tropicalis and the identification of integration sites by modified extension primer tag selection (EPTS) linker-mediated PCR.
  27. (1996). Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles.
  28. (2008). Karotyping mouse cells. Cold Spring Harb Protoc:
  29. (2005). Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia.
  30. (1997). Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice.
  31. (1989). Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.
  32. (2003). Molecular viral oncology of hepatocellular carcinoma.
  33. (2004). Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
  34. (1990). others a
  35. (1991). Production and effect of infectious Dane particles in transgenic mice.
  36. (1993). Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
  37. (2010). S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis.
  38. (2007). Signal integration in the endoplasmic reticulum unfolded protein response.
  39. (1998). Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.
  40. (1972). Standard karyotype of the mouse, Mus musculus.
  41. (1998). Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferatoractivated receptor alpha natural ligand metabolism.
  42. (1987). Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice.
  43. (2002). Survival characteristics and age-adjusted disease incidences in C57BL/6 mice fed a commonly used cereal-based diet modulated by dietary restriction.
  44. (2007). The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
  45. (1991). The role of envelope proteins in hepatitis B virus assembly.
  46. (2004). The role of the unfolded protein response in tumour development: friend or foe?
  47. (1991). The ubiquitous transcription factor Oct-1 and the liver-specific factor HNF-1 are both required to activate transcription of a hepatitis B virus promoter.
  48. (2001). XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.